Market Overview:
The Japan dry eye syndrome market size reached US$ 140.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 194.3 Million by 2032, exhibiting a growth rate (CAGR) of 3.6% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 140.3 Million |
Market Forecast in 2032
|
US$ 194.3 Million |
Market Growth Rate 2024-2032 |
3.6% |
Dry eye syndrome, or keratoconjunctivitis sicca (KCS), is a medical disorder that occurs due to the lack of adequate moisture or lubrication on the surface of the eyes. It is a chronic ailment characterized by redness, itching, aching, discomfort, pain, burning sensation in the eyes and photophobia. It can be caused due to extensive computer usage, menopause, allergies, deficiency of vitamin A, laser surgeries and autoimmune diseases. The syndrome can be treated by administering artificial tears, lacrimal plugs, medications and various surgical procedures. It can also be prevented by wearing wraparound sunglasses or other protective eyewear.
The growth in the Japan dry eye syndrome market can be attributed to the rising geriatric population. Dry eye syndrome is also widely associated with various medical conditions, such as diabetes, Sjogren's syndrome, arthritis, thyroid disorders, lupus and scleroderma that is highly prevalent among the elderly population. In addition to this, the increasing inclination toward activities requiring excessive screen time is also impacting the occurrence of the syndrome. These activities cause a high strain on the eyes, leading to fatigue and lack of lubrication. Moreover, various product innovations, such as the development of functional visual acuity meter devices that can measure changes in continuous visual acuity over time, are providing a thrust to the market growth. In line with this, the widespread adoption of hyaluronic acid that assists in retaining moisture and effectively treating dry eye syndrome is positively impacting the market growth. Other factors, including significant improvements in diagnostic technologies, along with rising healthcare expenditure capacities of the masses, are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the Japan dry eye syndrome market report, along with forecasts at the country and regional levels from 2024-2032. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Breakup by Disease Type:
- Evaporative Dry Eye Syndrome
- Aqueous Dry Eye Syndrome
Breakup by Drug Type:
- Anti-inflammatory Drugs
- Lubricant Eye Drops
- Autologous Serum Eye Drops
Breakup by Product:
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- Kanto Region
- Kinki Region
- Central/ Chubu Region
- Kyushu-Okinawa Region
- Tohoku Region
- Chugoku Region
- Hokkaido Region
- Shikoku Region
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Million |
Segment Coverage |
Disease Type, Drug Type, Product, Distribution Channel, Region |
Region Covered |
Kanto Region, Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the Japan dry eye syndrome market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan dry eye syndrome market?
- What are the key regional markets?
- What is the breakup of the market based on the disease type?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the Japan dry eye syndrome market and who are the key players?
- What is the degree of competition in the industry?